interesting that the options issued to staff yesterday aren't exercisable unless the JORC reaches 1 million oz. They must still be reasonably bullish that they can get there.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
